Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.
Emphasizing improved scanning efficiency and enhanced imaging precision, Siemens Healthineers has unveiled two new photon-counting computed tomography (PCCT) systems at the Radiological Society of North American (RSNA) conference.
Offering a scan time of up to 491 mm/sec, the dual-source CT scanner Naeotom Alpha.Pro enables sedation-free scanning of children and facilitates less breath holding time in demanding exams for pulmonology patients, according to Siemens Healthineers.
Recently introduced at the RSNA conference, the dual-source photon-counting computed tomography (PCCT) scanner Naeotom Alpha.Pro offers a scan time of up to 491 mm/sec, according to Siemens Healthineers, the developer of the PCCT system. (Image courtesy of Siemens Healthineers.)
Siemens Healthineers said the Naeotom Alpha.Prime is the first single-source PCCT system and offers high performance scanning capabilities in a variety of settings ranging from emergency room exams to ambulatory settings. The company added that Naeotom Alpha.Prime utilizes artificial intelligence (AI) and automation to increase the efficiency of diagnostic exams as well as interventional radiology procedures.
As part of the Naeotom Alpha class, Siemens Healthineers noted that both of the PCCT systems enable high-resolution imaging at a 0.2 mm slice thickness, facilitating small abnormality detection without increasing radiation dosing.
(Editor’s note: For additional coverage from the RSNA conference, click here.)
“With the launch of the Naeotom Alpha class, we deliver on our promise to make the powerful photon-counting technology accessible to more clinicians and patients,” said Philipp Fischer, the head of computed tomography at Siemens Healthineers. “We experience how photon-counting CT impacts clinical decision-making and we are convinced that this technology determines the future of CT imaging. Now, we are taking a major step into the future with the introduction of the Naeotom Alpha class, extending photon-counting technology further across our portfolio.”
Siemens Healthineers noted the Naeotom Alpha.Prime and the Naeotom Alpha.Pro are pending 510(k) clearance from the FDA.
Recent Videos
Related Content
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025Article
For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Podcast
Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025Article
In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Podcast
Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025Article
While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
SNMMI: Can Multimodal Monitoring Bolster Outcomes with Pluvicto in Treating mCRPC?
June 22nd 2025Article
Multimodal treatment monitoring, including SPECT/CT exams 24 hours after treatment with Lu-177 PSMA-617, may have facilitated significantly shorter therapy durations and reduced side effects in patients with mCRPC, according to a two-year study presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
